Literature DB >> 28167287

Poly-sgRNA/siRNA ribonucleoprotein nanoparticles for targeted gene disruption.

Jong Seong Ha1, Jae Sung Lee2, Jaepil Jeong2, Hejin Kim2, Juyoung Byun1, Sang Ah Kim3, Hee Jae Lee1, Hak Suk Chung4, Jong Bum Lee5, Dae-Ro Ahn6.   

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein-9 nuclease (Cas9) can be used for the specific disruption of a target gene to permanently suppress the expression of the protein encoded by the target gene. Efficient delivery of the system to an intracellular target site should be achieved to utilize the tremendous potential of the genome-editing tool in biomedical applications such as the knock-out of disease-related genes and the correction of defect genes. Here, we devise polymeric CRISPR/Cas9 system based on poly-ribonucleoprotein (RNP) nanoparticles consisting of polymeric sgRNA, siRNA, and Cas9 endonuclease in order to improve the delivery efficiency. When delivered by cationic lipids, the RNP nanoparticles built with chimeric poly-sgRNA/siRNA sequences generate multiple sgRNA-Cas9 RNP complexes upon the Dicer-mediated digestion of the siRNA parts, leading to more efficient disruption of the target gene in cells and animal models, compared with the monomeric sgRNA-Cas9 RNP complex.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Gene delivery; Gene disruption; Poly-ribonucleoprotein; Rolling circle amplification

Mesh:

Substances:

Year:  2017        PMID: 28167287     DOI: 10.1016/j.jconrel.2017.02.007

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  In Vivo Editing of Macrophages through Systemic Delivery of CRISPR-Cas9-Ribonucleoprotein-Nanoparticle Nanoassemblies.

Authors:  Yi-Wei Lee; Rubul Mout; David C Luther; Yuanchang Liu; Laura Castellanos-García; Amy S Burnside; Moumita Ray; Gulen Yeşilbag Tonga; Joseph Hardie; Harini Nagaraj; Riddha Das; Erin L Phillips; Tristan Tay; Richard W Vachet; Vincent M Rotello
Journal:  Adv Ther (Weinh)       Date:  2019-08-15

Review 2.  Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Authors:  Brittany E Givens; Youssef W Naguib; Sean M Geary; Eric J Devor; Aliasger K Salem
Journal:  AAPS J       Date:  2018-10-10       Impact factor: 4.009

Review 3.  Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.

Authors:  Song Zhang; Jiangtao Shen; Dali Li; Yiyun Cheng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

4.  Loss of splicing factor IK impairs normal skeletal muscle development.

Authors:  Hye In Ka; Hyemin Seo; Youngsook Choi; Joohee Kim; Mina Cho; Seok-Yong Choi; Sujeong Park; Sora Han; Jinsu An; Hak Suk Chung; Young Yang; Min Jung Kim
Journal:  BMC Biol       Date:  2021-04-01       Impact factor: 7.431

Review 5.  Multimeric RNAs for efficient RNA-based therapeutics and vaccines.

Authors:  Dajeong Kim; Sangwoo Han; Yoonbin Ji; Sunghyun Moon; Hyangsu Nam; Jong Bum Lee
Journal:  J Control Release       Date:  2022-03-31       Impact factor: 11.467

6.  Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.

Authors:  Manjeet Deshmukh; Shigeki Nakagawa; Takaaki Higashi; Adam Vincek; Anu Venkatesh; Marina Ruiz de Galarreta; Anna P Koh; Nicolas Goossens; Hadassa Hirschfield; C Billie Bian; Naoto Fujiwara; Atsushi Ono; Hiroki Hoshida; Mohamed El-Abtah; Noor B Ahmad; Amaia Lujambio; Roberto Sanchez; Bryan C Fuchs; Klaas Poelstra; Jai Prakash; Yujin Hoshida
Journal:  Nanomedicine       Date:  2017-11-20       Impact factor: 6.096

7.  Shaping Rolling Circle Amplification Products into DNA Nanoparticles by Incorporation of Modified Nucleotides and Their Application to In Vitro and In Vivo Delivery of a Photosensitizer.

Authors:  Kyoung-Ran Kim; Pascal Röthlisberger; Seong Jae Kang; Kihwan Nam; Sangyoup Lee; Marcel Hollenstein; Dae-Ro Ahn
Journal:  Molecules       Date:  2018-07-23       Impact factor: 4.411

8.  TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells.

Authors:  Jonathan Yen; Michael Fiorino; Yi Liu; Steve Paula; Scott Clarkson; Lisa Quinn; William R Tschantz; Heath Klock; Ning Guo; Carsten Russ; Vionnie W C Yu; Craig Mickanin; Susan C Stevenson; Cameron Lee; Yi Yang
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

Review 9.  CRISPR therapeutic tools for complex genetic disorders and cancer (Review).

Authors:  Stella Baliou; Maria Adamaki; Anthony M Kyriakopoulos; Demetrios A Spandidos; Mihalis Panayiotidis; Ioannis Christodoulou; Vassilis Zoumpourlis
Journal:  Int J Oncol       Date:  2018-06-06       Impact factor: 5.650

10.  Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.

Authors:  Piyush K Jain; Justin H Lo; Santosh Rananaware; Marco Downing; Apekshya Panda; Michelle Tai; Srivatsan Raghavan; Heather E Fleming; Sangeeta N Bhatia
Journal:  Nanoscale       Date:  2019-10-31       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.